Social Media Ideas for Retatrutide

<![CDATA[Retatrutide Delivers Up to 22.6% Weight Loss in Two New Phase III Trials]]>

7 Best Places to Buy Retatrutide in 2026

Photo by Alexander Mass This post may contain affiliate links. Read the full disclosure here. Retatrutide (LY3437943; The post 7 Best Places to Buy Retatrutide in 2026 appeared fir...

Lilly, with new data, to seek FDA approval of obesity drug retatrutide

The new findings position Lilly to file an application for the highly anticipated medicine, but also leave some questions about the additive benefits a “triple-G” drug has on heart...

Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide

Ahead of an approval filing, the drugmaker is amping up a fight against sellers who claim to offer versions of its highly anticipated “triple-G” weight loss medicine.

GLP-1 reduces rates of post-bariatric hypoglycemia

A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults after Roux-en-Y gastric bypass, according to topline results from a phase 3 tria...

Biohackers Think Retatrutide Will Be Bigger Than Ozempic. Does the Science Check Out?

An unapproved weight-loss drug is purportedly a longevity hack.

Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clear

Eli Lilly’s triple-G drug retatrutide has hit the primary endpoints of a pair of phase 3 obesity trials, although the peak weight loss fell short of previous trials while failing t...

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Reytorpyk for Advanced Breast Cancer]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Simtriyo]]>

The Newest Tirzepatide Request Is Convenience: California Trim Clinic Brings Oral GLP-1 Care Into the Conversation

The GLP-1 conversation is shifting from whether medical weight-loss treatment works to how comfortably it fits into everyday life. California Trim Clinic is responding with a docto...